methyl methoxyacetate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 80507 |
| CHEBI ID | 34841 |
| SCHEMBL ID | 29374 |
| MeSH ID | M0090121 |
| Synonym |
|---|
| brn 1742944 |
| ai3-22758 |
| einecs 228-539-9 |
| nsc 6701 |
| nsc 61447 |
| methyl-2-methoxyacetate |
| acetic acid, 2-methoxy-, methyl ester |
| 4-03-00-00578 (beilstein handbook reference) |
| n960nq69lf , |
| unii-n960nq69lf |
| AKOS008905286 |
| methoxyacetic acid, methyl ester |
| methoxyacetic acid methyl ester |
| methyl 2-methoxyacetate |
| nsc6701 |
| nsc-6701 |
| 6290-49-9 |
| methyl methoxyacetate |
| cbc 108569 |
| acetic acid, methoxy-, methyl ester |
| nsc-61447 |
| nsc61447 |
| methyl methoxyacetate, 99% |
| qrmhdgwglnlhmn-uhfffaoysa- |
| inchi=1/c4h8o3/c1-6-3-4(5)7-2/h3h2,1-2h3 |
| M0863 |
| 115171-85-2 |
| A803382 |
| FT-0628335 |
| SCHEMBL29374 |
| methoxy acetic acid methyl ester |
| methyl metoxyacetate |
| methoxy-acetic acid methyl ester |
| methyl methoxylacetate |
| CHEBI:34841 |
| methyl .alpha.-methoxyacetate |
| aceticacid,methoxy-,methyl |
| DTXSID3074608 |
| J-522037 |
| F0001-1705 |
| methyl methoxyacetate 99% |
| mfcd00008451 |
| methy methoxy acetate |
| Q27116293 |
| AS-10783 |
| EN300-84757 |
| AMY4063 |
| F53343 |
| Class | Description |
|---|---|
| methyl ester | Any carboxylic ester resulting from the formal condensation of a carboxy group with methanol. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (37.64) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||